Contraceptives Market 2018: Study on Eminent Players | Actavis, Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser, Mayer Laboratories, Merck & Co, Pfizer, Cooper Surgical and Church & Dwight Co.

Contraceptives Market to exceed USD 35 billion by 2024 as per a new research report.
Increasing prevalence of sexually transmitted diseases such as HIV/AIDS across the globe will drive the contraceptives market growth over the forecast timeframe. Unmet demand of contraceptives is expected to boost the industry growth. Developing countries have witness rapid increase in population over last few decades. Government initiative to control rapidly increasing population and rising awareness pertaining to the modern contraceptive measures should fuel global industry growth.

R&D activities focused on developing more effective contraceptive methods should serve as a high impact rendering factor. Growing number of females of reproductive age is anticipated to intensify the demand for devices.

Contraceptives market growth may be hindered by increasing geriatric population in many European countries. Several concerns pertaining to side effects are expected to impede the market growth over the forecast timeline.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/430

Advantages such as high usage convenience and reliability associated with the oral contraceptive pills should drive the oral contraceptives segment growth over the forecast period. However, side effects like venous thromboembolism, headaches may limit segment growth to some extent.

Intra-uterine devices dominated the industry owing to great demand because of their high degree of effectiveness. Ability of the copper intra-uterine device to offer more than 99% effectiveness will boost industry growth. Increasing preference among women who do not want to use hormonal form of contraceptives because of possible side effects will further lead to increase in market growth over the forecast period.

U.S. contraceptives market dominated the industry in North America owing to increasing educational programs to upsurge awareness levels and high number of women of reproductive age. Germany holds the largest regional market share due to growing need to prevent unwanted pregnancies along with growing prevalence of sexually transmitted diseases and high awareness pertaining to the modern contraceptives like Copper IUD and Hormonal IUD.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/430

Favorable government initiatives to control increasing population will drive the China contraceptives market. High prevalence of sexually transmitted diseases and increasing acceptance of premarital sex in the country should further fuel industry growth.

Some of the notable industry players are Actavis, Teva Pharmaceutical Industries, The Female Health Company, Reckitt Benckiser, Mayer Laboratories, Merck & Co, Pfizer, Cooper Surgical and Church & Dwight Co. Major industry players are magnifying their focus on research and development activities coupled with considerable number of products in their pipeline. They are also emphasizing on collaborations and partnerships to enhance their existing product portfolio.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.